Tomohiro Ohta
Overview
Explore the profile of Tomohiro Ohta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ryuno Y, Abe T, Tsukahara K, Watanabe J, Iino M, Saito S, et al.
Anticancer Res
. 2025 Mar;
45(3):1127-1136.
PMID: 40037876
Background/aim: Liver metastases are a major cause of cancer-related mortality and present significant therapeutic challenges. Chemotherapy is preferred for multiple metastases, while surgery or stereotactic body radiotherapy (SBRT) is used...
2.
Katano T, Suda S, Ohta T, Miyagami M, Kodaira Y, Konaka C, et al.
J Nippon Med Sch
. 2025 Jan;
91(6):527-533.
PMID: 39756941
Background: Rehabilitation therapists are sometimes unaware of the possibility of undiagnosed atrial fibrillation (AF) and the importance of AF detection. Thus, we aimed to increase awareness among rehabilitation therapists of...
3.
Aoshika T, Noda S, Abe T, Kumazaki Y, Hirai R, Igari M, et al.
Anticancer Res
. 2024 Mar;
44(4):1583-1589.
PMID: 38537975
Background/aim: Concurrent cisplatin-based chemoradiotherapy (CCRT) is the standard treatment for locally advanced cervical cancer. Especially, CCRT with magnetic resonance imaging (MRI) or computed tomography-based image-guided brachytherapy (CT-based 3D-IGBT) for cervical...
4.
Katano T, Suda S, Ohta T, Miyagami M, Kodaira Y, Konaka C, et al.
Front Neurol
. 2023 Sep;
14:1247020.
PMID: 37662047
Background: Cryptogenic stroke (CS) are heterogeneous in origin; however, most CS are embolic mechanism. Paroxysmal atrial fibrillation (AF) is suspected to be a major type of CS that leads to...
5.
Tanaka S, Iramina H, Kinjo M, Tsuneda M, Hirashima H, Kasamatsu K, et al.
Igaku Butsuri
. 2023 Jul;
43(2):54-55.
PMID: 37518587
No abstract available.
6.
Igari M, Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, et al.
Thorac Cancer
. 2023 Jul;
14(26):2642-2647.
PMID: 37466172
Background: Intensity-modulated radiotherapy (IMRT) has been increasingly used for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, there are some barriers to implementing IMRT for LA-NSCLC, including the...
7.
Hirai R, Ohta T, Igari M, Kumazaki Y, Iino M, Aoshika T, et al.
Anticancer Res
. 2023 Jun;
43(7):3265-3271.
PMID: 37351988
Background/aim: Combined intracavitary and interstitial brachytherapy (IC/IS-BT) is an effective treatment for extensive and bulky cervical cancer. However, the optimum number of interstitial needle applicators ("needles") inserted in IC/IS-BT can...
8.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, et al.
Anticancer Res
. 2023 Jan;
43(2):675-682.
PMID: 36697072
Background/aim: Efficacy and toxicity of concurrent chemoradiotherapy (CCRT) and durvalumab for locally advanced non-small cell lung cancer (LA-NSCLC) with N3 lymph node metastasis remain unclear. We aimed to evaluate the...
9.
Aoshika T, Abe T, Iino M, Saito S, Ryuno Y, Ohta T, et al.
Anticancer Res
. 2022 Dec;
42(12):6099-6103.
PMID: 36456125
Background/aim: Palliative radiotherapy is one of the effective treatments for pelvic tumors with bleeding or pain. In this study, we evaluated the safety and efficacy of palliative radiotherapy (RT) for...
10.
Abe T, Iino M, Saito S, Aoshika T, Ryuno Y, Ohta T, et al.
Thorac Cancer
. 2022 Sep;
13(20):2890-2896.
PMID: 36054298
Background: In this study, we developed a simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer (NSCLC) treated with...